Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies.
Saudi Pharm J
; 31(2): 228-244, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36540698
3CLpro, 3-Chymotrypsin -like Protease; ADMET, Absorption, distribution, metabolism, excretion and toxicity; CFR, Case fatality rate; DTT, Dithiothreitol; Drug Design; Drug Discovery; E. coli, Escherichia coli; EDTA, Ethylenediaminetetraacetic acid; HCoV-, Human Coronavirus; HIA, Human intestinal absorption; His-tag, Histidine tag; IPTG, Isopropyl b-D-1-thiogalactopyranoside; Inhibitors; Kan, Kanamicyn; LB, LuriaBertani; MD, Molecular dynamic; MERS-CoV PLpro Inhibitors; MOE, Molecular Operating Environment; MPLpro, MERS papain-like protease; Molecular Docking; Molecular dynamic simulation; Ni-NTA, Nickel-nitrilotri; Nonstructural proteins; PLIF, Protein- ligand interaction fingerprint; Papain-like protease; Protease; RMSD, Root Mean Square Deviation; RMSF, Root Mean Square Fluctuation; pp1a, Polyprotein 1a; pp1b, Polyprotein 1b
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Idioma:
En
Revista:
Saudi Pharm J
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Arábia Saudita